Want to join the conversation?
Leader in cardiac & neurological device technology $STJ posted diluted EPS of $0.75 vs. $0.82 in 3Q14. "3Q15 results confirm that innovation based growth program continues to gain traction. Now we are focused on efficiently integrating our acquisition of Thoratec & strengthening our entire portfolio of growth drivers for 2016," said Starks, CEO.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?